Valion Bio stockholders approve reverse split authority and equity plan increase
At a November 12, 2026 special meeting, Valion Bio shareholders backed a board option for a 1-for-2 to 1-for-12 reverse stock split and added 272,000 shares to its incentive plan.
SEC filing